Andson Biotech

Andson Biotech is focused on accelerating the discovery, development, and manufacturing of advanced cell-based therapies. Their mission is to overcome the challenges of prolonged development times, regulatory hurdles, and high manufacturing costs to make cutting-edge treatments accessible and affordable. Andson Biotech employs high-resolution mass spectrometry in their research, utilizing proteomics and metabolomics to gain insights into disease mechanisms. This approach enables them to identify and validate new therapeutic targets with high precision. Their research spans biologics, cell and gene therapies, tissue-engineered products, and modern vaccines. The company’s flagship products include Dynachip, a high-throughput mass spectrometry platform that provides detailed molecular profiling, and Dynamark, an analytics tool that integrates mass spectrometry data for target identification.